Review of current treatment in panic disorder

JA den Boer*, BR Slaap

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

30 Citaten (Scopus)

Samenvatting

The ideal properties for an antipanic agent include the ability to provide complete recovery from panic attacks, resolution of associated anxiety and avoidance behavior, relapse prevention, good tolerability, and efficacy in comorbid conditions including depression. We compared the properties of currently available treatment options for panic attacks, including the benzodiazepines, tricyclic antidepressants, monoamine oxidase inhibitors and selective serotonin reuptake inhibitors (SSRIs), with this ideal. Experimental approaches in the development of therapeutic agents of potential use against panic disorder were also examined. It is clear that SSRIs, such as paroxetine, are an effective treatment for panic disorder, and their antidepressant activity also allows concurrent treatment of comorbid depressive disorders, for which patients with panic disorder are at high risk. However, despite the availability of effective antipanic agents, some patients do not respond to treatment. (C) 1998 Lippincott-Raven Publishers.

Originele taal-2English
Pagina's (van-tot)S25-S30
Aantal pagina's6
TijdschriftINTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
Volume13
StatusPublished - apr.-1998
Evenement10th Annual Congress of the European-College-of-Neuropsychopharmacology - , Austria
Duur: 13-sep.-199717-sep.-1997

Citeer dit